Project 3: SRP Publications
Plasma Biomarkers and Parkinsonism in Welders

2013
Publications

READ Lock EA, Zhang J, Checkoway H. Solvents and Parkinson’s disease: a systematic review of toxicological and epidemiological evidence. Toxicol Appl Pharmacol 2013;266:345-55. PMCID: PMC3621032

2012
Publications

READAasly JO, Shi M, Sossi V, Stewart T, Johansen KK, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian, CP, Kim HM, Leverenz, JB, Ginghina C, Armaly J, Edwards K, Snapinn KW, Stoessl JA, and Zhang J. Cerebrospinal fluid Amyloid ß and tau in LRRK2 mutation carriers, Neurology, 2012, 3;78(1):55-61. PMCID: PMC3466497

READ Lin X, Cook TJ, Zabetian CP, Hwang H, Leverenz JB, Peskind ER, Hu S-C, Cain K, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J. DJ-1 isoforms in whole blood: potential markers for Parkinson disease diagnosis and progression. Sci Rep. 2:954, 2012 PMCID: PMC3518819

READ Racette BA, Criswell S, Lundin JL, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Checkoway H. Increased risk of parkinsonism associated with welding exposure. NeuroToxicol 2012;33:1356-61. PMCID: PMC3651999

READWang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VMY, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, and Zhang J. Phosphorylated alpha-synuclein in Parkinsonian disorders. Science (Translational Medicine). Sci Transl Med. 2012 Feb 15;4(121):121ra20. PMCID: PMC3302662

2011
Publications

READCriswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced Uptake of [18F]FDOPA PET in Asymptomatic Welders with Occupational Manganese Exposure. Neurology, 2011 Apr 12;76(15):1296-301.

READShi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Aasly J, Goldstein DS, Zhang J. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol, 2011 69(3):570-80. PMCID: PMC3117674

READShi M, Sui YT, Peskind ER, Li G, Hwang H, Devic I, Ginghina C, Edgar JS, Pan C, Goodlett DR, Furay AR, Gonzalez-Cuyar LF, Zhang J. Salivary tau species are potential biomarkers of Alzheimer's disease. J Alzheimer’s Dis. 2011;27(2):299-305 PMCID: PMC3302350

2010
Publications

READ Caudle WM, Bammler TK, Lin Y, Pan S, Zhang J. Using ‘omics’ to define pathogenesis and biomarkers of Parkinosn’s disease. Expert Rev Neurother. 2010,10:925-42. PMCID: PMC2913169

READ Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain. 2010 Mar;133(Pt 3):713-26. Epub 2010 Feb 15.

READHwang H, Zhang JP, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, and Zhang J. Glycoproteomics in Neurodegenerative Diseases. Mass Spectrometry Reviews, 2010 Jan-Feb;29(1):79-125. PMCID: PMC2799547

READ Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF Abeta(42) and tau in Parkinson's disease with cognitive impairment. Mov Disord. 2010 Sep 3.

READ Shi M, huber BR, Zhang J. Biomarkers for cognitive impairment in Parkinson disease. Brain Pathol. 2010 May;20(3):660-71

READ Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett. 2010 Aug 9;480(1):78-82. Epub 2010 Jun 9.

 
 
© 2007-2014 Department of Environmental and Occupational Health Sciences, University of Washington
CONTACT US